There is good news for all those looking for a professional review of current research and development in oncology and hematology relevant for daily practice: the digital twin of the established Springer Magazine of European Medical Oncology (memo) has been relaunched with a new structure and design.

Update to manage a wealth of information

What started out as a virtual repository for congress reports the main international oncology and hematology meetings has developed into a hub covering as many as 27 oncological and hematological indications. To make the plethora of information more easily searchable, the site is now organised into different categories.

Expert interviews are integral part of the memoinoncology website

What is new?

Digital versions of congress digests with specific foci still offer special insights into defined indication and therapy areas. However, sub indications have received their own dedicated space and will now also update readers of developments outside congresses. Validated by medical societies, congress reports are currently available in English. The coverage is broad and not company-specific, presenting insights into a wide variety of studies in the context of the current treatment paradigm.

Video expert interviews provide a perspective on the latest findings. You can find them either next to the relevant congress report or in their own section. If you are interested in a particular expert’s perspective on the latest research or if you would like to review existing commentaries, you can browse the video section searching for particular topics and/or interviews.

The collection section guides you to further reading, information about our collaboration partners in medical societies and pharma and downloadable materials.

You may already know us and our LinkedIn updates on what is new in the hub. Posts are now directly linked to the relevant section on the website. If you are not doing so already, please follow us here to receive the latest updates in oncology and hematology.  We look forward to counting you among our readers and the research community!